ChemFaces is a professional high-purity natural products manufacturer.
Product Intended Use
1. Reference standards
2. Pharmacological research
3. Inhibitors
Taccalonolide AJ
Citing Use of our Products
How to Order
Orders via your E-mail:
1. Product number / Name / CAS No.
2. Delivery address
3. Ordering/billing address
4. Contact information
Sent to Email: info@chemfaces.com
Contact Us
Order & Inquiry & Tech Support
Tel: (0086)-27-84237683
Fax: (0086)-27-84254680
E-mail: manager@chemfaces.com
Address: No. 83, CheCheng Rd., WETDZ, Wuhan, Hubei 430056, PRC
Delivery time
Delivery & Payment method
1. Usually delivery time: Next day delivery by 9:00 a.m. Order now
2. We accept: Wire transfer & Credit card & Paypal & Western Union
* Packaging according to customer requirements(5mg, 10mg, 20mg and more). We shipped via FedEx, DHL, UPS, EMS and others courier.
According to end customer requirements, ChemFaces provide solvent format. This solvent format of product intended use: Signaling Inhibitors, Biological activities or Pharmacological activities.
| Size /Price /Stock |
10 mM * 1 mL in DMSO / $413.4 / In-stock |
Other Packaging |
*Packaging according to customer requirements(100uL/well, 200uL/well and more), and Container use Storage Tube With Screw Cap |
More articles cited ChemFaces products.
BMC Complement Altern Med.2014, 14:352Reprod Toxicol.2020, 96:1-10. J Cell Mol Med.2022, 26(23):5807-5819.J Nat Med.2020, 74(1):65-75Molecules.2019, 24(10):E1926Food Res Int.2021, 148:110607.Biomedicines.2021, 9(8):954.J of Apicultural Research2020, 10.1080
Neurochem Int.2020, 133:104629J Food Compos Anal2017, 62:197-204Saudi Pharm J.2019, 27(1):145-153Biomed Chromatogr.2016, 30(10):1573-81Int J Mol Sci.2021, 22(16):8641.J Agric Food Chem....2022...Histol Histopathol.2022, 18518.Environ Toxicol Pharmacol....2019...
Processes2021, 9(5),831.Drug Invention Today...2019...Pharmaceuticals.2022, 15(4), 402.Phytomedicine.2022, 100:154085.Toxicol In Vitro.2022, 81:105346. J Ethnopharmacol.2017, 198:91-97Life (Basel).2021, 11(7):616.
More...
Our products had been exported to the following research institutions and universities, And still growing.
University of Indonesia (Indonesia)Semmelweis Unicersity (Hungary)Copenhagen University (Denmark)Colorado State University (USA)
Lodz University of Technology (Poland)Vin?a Institute of Nuclear Scie... (Serbia)MTT Agrifood Research Finland (Finland)University of Minnesota (USA)
University of Canterbury (New Zealand)Harvard University (USA)Heidelberg University (Germany)
More...
Taccalonolide AJ
Inquire / Order:
manager@chemfaces.com
Technical Inquiries:
service@chemfaces.com
Tel:
+86-27-84237783
Fax:
+86-27-84254680
Address:
1 Building, No. 83, CheCheng Rd., Wuhan Economic and Technological Development Zone, Wuhan, Hubei 430056, PRC
J Funct Foods2019, 54:449-456Molecules.2021, 26(4):816. Biomedicine & Pharmacotherapy2022, 153:113404.J Pharm Pharmacol.2022, rgac033. Biorxiv.2020, doi: 10.1101.Process Biochemistry2019, 85:106-115J Microbiol Biotechnol.2020, 30(2):178-186.Postharvest Biol Tec2019, 149:18-26J Sci Food Agric.2022, 102(4):1628-1639Plant Cell,Tissue & Organ Culture2016, 127(1):115-121
Related Screening Libraries
| Description: |
Taccalonolide AJ is a microtubule stabilizer; it has excellent and highly persistent antitumor efficacy when administered directly to the tumor, suggesting that the lack of antitumor efficacy seen with systemic administration of AJ is likely due to its short half-life in vivo. |
| In vivo: |
| J Nat Prod. 2017 Feb 24;80(2):409-414. | | Pharmacokinetic Analysis and in Vivo Antitumor Efficacy of Taccalonolides AF and AJ.[Pubmed: 28112516 ] | The taccalonolides are microtubule stabilizers that covalently bind tubulin and circumvent clinically relevant forms of resistance to other drugs of this class. Efforts are under way to identify a taccalonolide with optimal properties for clinical development. The structurally similar taccalonolides AF and AJ have comparable microtubule-stabilizing activities in vitro, but taccalonolide AF has excellent in vivo antitumor efficacy when administered systemically, while Taccalonolide AJ does not elicit this activity even at maximum tolerated dose.
METHODS AND RESULTS:
The hypothesis that pharmacokinetic differences underlie the differential efficacies of taccalonolides AF and AJ was tested. The effects of serum on their in vivo potency, metabolism by human liver microsomes and in vivo pharmacokinetic properties were evaluated. Taccalonolides AF and AJ were found to have elimination half-lives of 44 and 8.1 min, respectively. Furthermore, Taccalonolide AJ was found to have excellent and highly persistent antitumor efficacy when administered directly to the tumor, suggesting that the lack of antitumor efficacy seen with systemic administration of AJ is likely due to its short half-life in vivo.
CONCLUSIONS:
These results help define why some, but not all, taccalonolides inhibit the growth of tumors at systemically tolerable doses and prompt studies to further improve their pharmacokinetic profile and antitumor efficacy. |
|
Taccalonolide AJ Description
| Source: |
The rhizomes of Schizocapsa plantaginea Hance |
| Solvent: |
Chloroform, Dichloromethane, Ethyl Acetate, DMSO, Acetone, etc. |
| Storage: |
Providing storage is as stated on the product vial and the vial is kept tightly sealed, the product can be stored for up to 24 months(2-8C).
Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20C. Generally, these will be useable for up to two weeks. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.
Need more advice on solubility, usage and handling? Please email to: service@chemfaces.com
|
| After receiving: |
The packaging of the product may have turned upside down during transportation, resulting in the natural compounds adhering to the neck or cap of the vial. take the vial out of its packaging and gently shake to let the compounds fall to the bottom of the vial. for liquid products, centrifuge at 200-500 RPM to gather the liquid at the bottom of the vial. try to avoid loss or contamination during handling. |
ChemFaces New Products and Compounds
Recently, ChemFaces products have been cited in many studies from excellent and top scientific journals
Cell. 2018 Jan 11;172(1-2):249-261.e12. doi: 10.1016/j.cell.2017.12.019.
IF=36.216(2019)PMID: 29328914
Cell Metab. 2020 Mar 3;31(3):534-548.e5. doi: 10.1016/j.cmet.2020.01.002.
IF=22.415(2019)PMID: 32004475
Mol Cell. 2017 Nov 16;68(4):673-685.e6. doi: 10.1016/j.molcel.2017.10.022.
IF=14.548(2019)PMID: 29149595
ACS Nano. 2018 Apr 24;12(4): 3385-3396. doi: 10.1021/acsnano.7b08969.
IF=13.903(2019)PMID: 29553709
Nature Plants. 2016 Dec 22;3: 16206. doi: 10.1038/nplants.2016.205.
IF=13.297(2019)PMID: 28005066
Sci Adv. 2018 Oct 24;4(10): eaat6994. doi: 10.1126/sciadv.aat6994.
IF=12.804(2019)PMID: 30417089
Calculate Dilution Ratios(Only for Reference)
|
1 mg |
5 mg |
10 mg |
20 mg |
25 mg |
| 1 mM |
1.4778 mL |
7.3888 mL |
14.7776 mL |
29.5552 mL |
36.944 mL |
| 5 mM |
0.2956 mL |
1.4778 mL |
2.9555 mL |
5.911 mL |
7.3888 mL |
| 10 mM |
0.1478 mL |
0.7389 mL |
1.4778 mL |
2.9555 mL |
3.6944 mL |
| 50 mM |
0.0296 mL |
0.1478 mL |
0.2956 mL |
0.5911 mL |
0.7389 mL |
| 100 mM |
0.0148 mL |
0.0739 mL |
0.1478 mL |
0.2956 mL |
0.3694 mL |
* Note: If you are in the process of experiment, it's need to make the dilution ratios of the samples. The dilution data of the sheet for your reference. Normally, it's can get a better solubility within lower of Concentrations.
| Kinase Assay: |
| Biochem Pharmacol. 2013 Apr 15;85(8):1104-14. | | Chemically diverse microtubule stabilizing agents initiate distinct mitotic defects and dysregulated expression of key mitotic kinases.[Pubmed: 23399639] |
METHODS AND RESULTS:
Microtubule stabilizers are some of the most successful drugs used in the treatment of adult solid tumors and yet the molecular events responsible for their antimitotic actions are not well defined. The mitotic events initiated by three structurally and biologically diverse microtubule stabilizers; Taccalonolide AJ, laulimalide/fijianolide B and paclitaxel were studied. These microtubule stabilizers cause the formation of aberrant, but structurally distinct mitotic spindles leading to the hypothesis that they differentially affect mitotic signaling. Each microtubule stabilizer initiated different patterns of expression of key mitotic signaling proteins. Taccalonolide AJ causes centrosome separation and disjunction failure to a much greater extent than paclitaxel or laulimalide, which is consistent with the distinct defects in expression and activation of Plk1 and Eg5 caused by each stabilizer. Localization studies revealed that TPX2 and Aurora A are associated with each spindle aster formed by each stabilizer. This suggests a common mechanism of aster formation. However, Taccalonolide AJ also causes pericentrin accumulation on every spindle aster. The presence of pericentrin at every spindle aster initiated by Taccalonolide AJ might facilitate the maintenance and stability of the highly focused asters formed by this stabilizer. Laulimalide and paclitaxel cause completely different patterns of expression and activation of these proteins, as well as phenotypically different spindle phenotypes.
CONCLUSIONS:
Delineating how diverse microtubule stabilizers affect mitotic signaling pathways could identify key proteins involved in modulating sensitivity and resistance to the antimitotic actions of these compounds. |
|
Tags: buy Taccalonolide AJ | Taccalonolide AJ supplier | purchase Taccalonolide AJ | Taccalonolide AJ cost | Taccalonolide AJ manufacturer | order Taccalonolide AJ | Taccalonolide AJ distributor
